Allena Pharmaceuticals, Inc.
ALNAQOTCHealthcare
$0.00
$-0.00(-99.00%)
Market Cap$122
P/E Ratio—
52W High—
52W Low—
Allena Pharmaceuticals, Inc. (ALNAQ) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALNAQ · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2022Report Date: Aug 15, 2022EPS Actual
-$0.08
Est. -$0.07 · -14.3%
Revenue
—
Fiscal Period
Q3 FY2022
FY ends December
Report Date
Aug 15, 2022
After Market Close
▼ Miss EPS
ALNAQ reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2023 | Nov 13, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Sep 22, 2023 | — | — | — | — | — | — |
| ◌ Q2 FY2023 | Jun 28, 2023 | — | — | — | — | — | — |
| ◌ Q1 FY2023 | Feb 24, 2023 | — | — | — | — | — | — |
| ◌ Q4 FY2022 | Dec 16, 2022 | -$0.05 | — | — | — | — | — |
| ▼ Q3 FY2022 | Aug 15, 2022 | -$0.07 | -$0.08 | -14.3% | — | — | — |
| ▲ Q2 FY2022 | May 16, 2022 | -$0.14 | -$0.13 | +7.1% | — | — | — |
| ▲ Q1 FY2022 | Mar 31, 2022 | -$0.16 | -$0.11 | +31.3% | — | — | — |
Q4 FY2023
Nov 13, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Sep 22, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
Jun 28, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Feb 24, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Dec 16, 2022
EPS Actual
—
EPS Est.
-$0.05
EPS Surpr.
—
Revenue
—
Q3 FY2022
Aug 15, 2022Miss
EPS Actual
-$0.08
EPS Est.
-$0.07
EPS Surpr.
-14.3%
Revenue
—
Q2 FY2022
May 16, 2022Beat
EPS Actual
-$0.13
EPS Est.
-$0.14
EPS Surpr.
+7.1%
Revenue
—
Q1 FY2022
Mar 31, 2022Beat
EPS Actual
-$0.11
EPS Est.
-$0.16
EPS Surpr.
+31.3%
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.52 | $1.52 | $1.52 | 0 |
| Q2 FY2024 | $1.32 | $1.32 | $1.32 | 0 |
| Q1 FY2024 | $1.55 | $1.55 | $1.55 | 0 |
| Q4 FY2023 | $2.08 | $2.08 | $2.08 | 0 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 0 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2022 | Aug 15, 2022 | -14.3% | $0.12 | $0.12 | +0.83% |
| ▲ Q2 FY2022 | May 16, 2022 | +7.1% | $0.12 | $0.11 | -7.79% |
| ▲ Q1 FY2022 | Mar 31, 2022 | +31.3% | $0.23 | $0.23 | -0.09% |
| ▲ Q4 FY2021 | Nov 10, 2021 | +5.6% | $0.96 | $0.89 | -7.31% |
| ▼ Q3 FY2021 | Aug 10, 2021 | -14.3% | $0.99 | $0.96 | -2.56% |
| ▲ Q2 FY2021 | May 11, 2021 | +8.7% | $1.10 | $1.16 | +5.45% |
| ▼ Q1 FY2021 | Mar 9, 2021 | -26.3% | $1.52 | $1.51 | -0.66% |
Q3 FY2022+0.83%
Report Date
Aug 15, 2022
EPS Beat/Miss
-14.3%
Price Before
$0.12
Price After
$0.12
Q2 FY2022-7.79%
Report Date
May 16, 2022
EPS Beat/Miss
+7.1%
Price Before
$0.12
Price After
$0.11
Q1 FY2022-0.09%
Report Date
Mar 31, 2022
EPS Beat/Miss
+31.3%
Price Before
$0.23
Price After
$0.23
Q4 FY2021-7.31%
Report Date
Nov 10, 2021
EPS Beat/Miss
+5.6%
Price Before
$0.96
Price After
$0.89
Q3 FY2021-2.56%
Report Date
Aug 10, 2021
EPS Beat/Miss
-14.3%
Price Before
$0.99
Price After
$0.96
Q2 FY2021+5.45%
Report Date
May 11, 2021
EPS Beat/Miss
+8.7%
Price Before
$1.10
Price After
$1.16
Q1 FY2021-0.66%
Report Date
Mar 9, 2021
EPS Beat/Miss
-26.3%
Price Before
$1.52
Price After
$1.51
Avg Beat Reaction-2.43%
Avg Miss Reaction-0.80%
Beat Rate4 / 7 quarters
Largest Move-7.79% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALNAQ ends December
Allena Pharmaceuticals, Inc. (ALNAQ) most recently reported earnings on August 15, 2022 for Q3 FY2022, posting EPS of $-0.08 — missing the analyst consensus of $-0.07 by -14.3%. The next ALNAQ earnings date is expected around September 1, 2026.
Each quarter, investors track ALNAQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALNAQ revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALNAQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALNAQ earnings · 5 questionsAllena Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. ALNAQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALNAQ historically reports after market close (AMC).
ALNAQ earnings datewhen is ALNAQ earningsALNAQ next earnings datewhen does ALNAQ report earningsALNAQ earnings calendar
▸ Source: FMP · Allena Pharmaceuticals, Inc. SEC filings · US GAAP · Allena Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026